Co-Authors
This is a "connection" page, showing publications co-authored by Vito Lampasona and Lorenzo Piemonti.
Connection Strength
3.950
-
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia. 2020 12; 63(12):2548-2558.
Score: 0.907
-
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19. Metabolism. 2021 10; 123:154845.
Score: 0.240
-
Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia. Biology (Basel). 2021 Aug 05; 10(8).
Score: 0.240
-
Dysglycemia after COVID-19 pneumonia: a six-month cohort study. Acta Diabetol. 2021 Nov; 58(11):1481-1490.
Score: 0.237
-
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia. J Clin Endocrinol Metab. 2021 04 23; 106(5):1472-1481.
Score: 0.235
-
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J Clin Invest. 2020 12 01; 130(12):6366-6378.
Score: 0.229
-
Measurement of Autoantibodies to Gastric H+,K+-ATPase (ATP4A/B) Using a Luciferase Immunoprecipitation System (LIPS). Methods Mol Biol. 2019; 1901:113-131.
Score: 0.201
-
Study of 2009 H1N1 Pandemic Influenza Virus as a Possible Causative Agent of Diabetes. J Clin Endocrinol Metab. 2018 12 01; 103(12):4343-4356.
Score: 0.199
-
Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome. Pancreatology. 2018 Dec; 18(8):945-953.
Score: 0.197
-
A novel LIPS assay for insulin autoantibodies. Acta Diabetol. 2018 Mar; 55(3):263-270.
Score: 0.187
-
No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay. Cancer Biomark. 2018; 22(2):351-357.
Score: 0.187
-
miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA. Sci Rep. 2017 10 25; 7(1):14051.
Score: 0.185
-
Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific. Diabetologia. 2017 09; 60(9):1834-1835.
Score: 0.181
-
Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients. Clin Transl Gastroenterol. 2017 Jan 19; 8(1):e215.
Score: 0.175
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
Score: 0.060
-
Young infants exhibit robust functional antibody responses and restrained IFN-? production to SARS-CoV-2. Cell Rep Med. 2021 07 20; 2(7):100327.
Score: 0.059
-
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021 05 11; 12(1):2670.
Score: 0.059
-
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report. Front Immunol. 2020; 11:603428.
Score: 0.057
-
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children. Med (N Y). 2021 Feb 12; 2(2):149-163.e4.
Score: 0.057
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
Score: 0.057